NRAMP1 gene polymorphisms in patients with rheumatoid arthritis

被引:37
|
作者
Singal, DP [1 ]
Li, J [1 ]
Zhu, Y [1 ]
Zhang, G [1 ]
机构
[1] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada
来源
TISSUE ANTIGENS | 2000年 / 55卷 / 01期
关键词
NRAMP1; rheumatoid arthritis;
D O I
10.1034/j.1399-0039.2000.550107.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Rheumatoid arthritis (RA) is a chronic inflammatory joint disease associated with HLA-DR genes that share amino acid sequence motif QKRAA/QRRZA from position 70 to 74 in the third hypervariable region of DR1 molecule. The contribution of HLA in RA is however about 37%, suggesting a role for other genes. One such candidate is the gene that encodes natural resistance-associated macrophage protein (NRAMP1), which plays a crucial role in inflammation and tissue destruction. Ln the present study, we examined the role of NRAMP1 gene polymorphisms in susceptibility to RA. The results show that variation at position 543 in exon 15, which involves substitution of negatively charged aspartic acid (D) by uncharged asparagine (N), and the deletion of TGTG in the 3' UTR may confer protection from development of RA.
引用
收藏
页码:44 / 47
页数:4
相关论文
共 50 条
  • [41] Tristetraprolin Gene Single-Nucleotide Polymorphisms and mRNA Level in Patients With Rheumatoid Arthritis
    Yang, Xiaoke
    Chen, Bo
    Zhang, Mingyue
    Xu, Shengqian
    Shuai, Zongwen
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [42] LRP5 gene polymorphisms and radiographic joint damage in rheumatoid arthritis patients
    M. Bernardes
    C. Durães
    A. Oliveira
    M. J. Martins
    R. Lucas
    L. Costa
    J. G. Pereira
    I. Ramos
    J. C. Machado
    F. Simões-Ventura
    Osteoporosis International, 2018, 29 : 2355 - 2368
  • [43] Natural resistance-associated macrophage protein 1 gene polymorphisms in rheumatoid arthritis
    Yen, JH
    Lin, CH
    Tsai, WC
    Ou, TT
    Wu, CC
    Hu, CJ
    Liu, HW
    IMMUNOLOGY LETTERS, 2006, 102 (01) : 91 - 97
  • [44] Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis
    Cruyssen, B. Vander
    Nuytinck, L.
    Boullart, L.
    Elewaut, D.
    Waegeman, W.
    Van Thielen, M.
    De Meester, E.
    Lebeer, K.
    Rossau, R.
    De Keyser, F.
    RHEUMATOLOGY, 2007, 46 (12) : 1792 - 1795
  • [45] Itch gene polymorphisms in healthy population and in patients affected by rheumatoid arthritis and atopic dermatitis
    Bernardini, Sergio
    Gravina, Paolo
    Croce, Nicoletta
    Perricone, Roberto
    Knight, Richard A.
    Valentini, Alessandra
    Melino, Gerry
    Federici, Giorgio
    CELL CYCLE, 2008, 7 (22) : 3607 - 3609
  • [46] LRP5 gene polymorphisms and radiographic joint damage in rheumatoid arthritis patients
    Bernardes, M.
    Duraes, C.
    Oliveira, A.
    Martins, M. J.
    Lucas, R.
    Costa, L.
    Pereira, J. G.
    Ramos, I.
    Machado, J. C.
    Simoes-Ventura, F.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 (10) : 2355 - 2368
  • [47] Effect of MTHFR, TGFβ1, and TNFB polymorphisms on osteoporosis in rheumatoid arthritis patients
    Saad, Mohamed N.
    Mabrouk, Mai S.
    Eldeib, Ayman M.
    Shaker, Olfat G.
    GENE, 2015, 568 (02) : 124 - 128
  • [48] Polymorphisms of Genes for Programmed Cell Death 1 Ligands in Patients with Rheumatoid Arthritis
    Shu-Chen Wang
    Chia-Hui Lin
    Ruei-Nian Li
    Tsan-Teng Ou
    Cheng-Chin Wu
    Wen-Chan Tsai
    Hong-Wen Liu
    Jeng-Hsien Yen
    Journal of Clinical Immunology, 2007, 27 : 563 - 567
  • [49] Vascular Endothelial Growth Factor Gene Polymorphisms and Rheumatoid Arthritis
    Lv, Hao-zhe
    Lin, Tao
    Xia, Li-ping
    Shen, Hui
    Zhu, Xiang-yang
    Zhang, Jin-tao
    Xiao, Wei-guo
    Lu, Jing
    JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (03) : 593 - 598
  • [50] The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy
    Tarnowski, Maciej
    Paradowska-Gorycka, Agnieszka
    Dabrowska-Zamojcin, Ewa
    Czerewaty, Michal
    Sluczanowska-Glabowska, Sylwia
    Pawlik, Andrzej
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (01) : 41 - 55